MedCity News

Mount Sinai Drops Anthem Following Contract Dispute

Doctors and the Virtual Medical Revolution and Technological Advances Artificial Intelligence (AI) Deep Learning for Medical Research and Future Health Technology

Third Way Health Secures $15M to Streamline Front-Office Operations for Medical Practices

Third Way Health's Series A round was from Health Velocity Capital, led by partner Kristin Torres Mowat. In total, Third Way Health has raised $22.5 million.

By Marissa Plescia

BioPharma, Legal

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology

Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If Moderna's full financial payout to the companies is reached, it would rank among the largest disclosed patent settlements in biopharmaceutical industry history.

By Frank Vinluan

MedCity Influencers

AI, VR, and the Training Gap: Why New Healthcare Tech Fails Without Workforce Readiness

The problem isn’t whether these modalities work, but how they’re being implemented into the workforce. Efficient rollout, proper training, and ongoing education are vital for these new methods to reach their full potential.

By Lora Sparkman

Latest Video

Latest News

MedCity Influencers

The Future of Pharmacy is Now – Health Systems Must Act to Drive Innovation, Access and Sustainability

By embracing innovation, optimizing operations and advocating for change, pharmacy leaders can ensure their organizations are not only prepared for the future but are actively shaping it.

By Matt Glucksmann

BioPharma, Pharma

Disc Medicine Rare Disease Drug Picked for Faster Regulatory Review Is Rejected by the FDA

The FDA asked for more data to determine whether Disc Medicine’s bitopertin is benefiting patients with erythropoietic protoporphyria, a rare blood disorder. Analysts say it’s a surprising delay considering bitopertin is one of the first drugs in a new FDA pilot program that speeds up regulatory review of medicines deemed critical for national security or public health.

By Frank Vinluan

Artificial Intelligence, Hospitals, Health Tech, Providers

Artificial intelligence helps doctors analyze medical data for accurate treatment, store and analyze patient data.

NYU Langone Health: We’re Close to Clinical AI with No Human in the Loop

Health informatics leaders at NYU Langone Health think fully autonomous clinical AI is coming in the next five years or so, with algorithms soon able to manage routine tasks like blood pressure medication titration and diabetic retinopathy screening without human oversight. They argue automation is not just about efficiency, but also a practical and necessary solution to workforce shortages and system inefficiencies.

By Katie Adams

MedCity Influencers

From Pilots to Protocols: Why VR Therapy Needs Dosage Standards to Become Real Clinical Care

When people hear dosage, they often think of medication. But dosage is a broader clinical concept. It is the structure that makes an intervention legible to clinicians, payers, and regulators. For VR therapy, dosage is the answer to simple questions that are still surprisingly inconsistent across studies and pilots.

By Nargiz Noimann

MedCity Influencers

Two people with business income and profits lifting dollar coin celebrating financial success and profitable company. Economy and finances concept in flat design vector

When Health Dollars Move to Individuals, Infrastructure Will Decide Who Wins

Shifting healthcare dollars into individual-controlled accounts would mark an inflection point. But even without full policy execution, consumer wallet economics are expanding. The race is now on to build the infrastructure layer between individual spending authority and care delivery.

By Dana Y. Lujan

Artificial Intelligence, Startups, Health Tech, Payers

Anterior Snags $40M to Speed Care Approvals with AI

Anterior raised $40 million to expand its AI platform that automates administrative clinical work for health plans. The system can approve care in minutes rather than weeks, aiming to reduce costs and ease the workload for clinicians and payer staff.

By Katie Adams

BioPharma, Pharma

PTC Therapeutics Ends Bid to Seek FDA Approval for Rare Muscle Disease Drug

PTC Therapeutics said it cannot resolve differences it has with the FDA in interpreting clinical trial data for Translarna, a drug it developed for Duchenne muscular dystrophy. The rare disease drug developer’s decision to withdraw Translarna’s FDA submission comes nearly a year after a negative European regulatory decision for the drug.

By Frank Vinluan

MedCity Influencers

Closing the CKD Care Gap with Value-Based Care Models

VBC models deliver significant benefits for CKD management by coordinating medical, behavioral, and social support through multidisciplinary teams. This approach enables providers to personalize care, address barriers to access, and use data-driven strategies to identify and prioritize high-risk patients.

By Heather Trafton

MedCity Influencers

AI Can’t Improve Healthcare if Clinicians and Staff Aren’t Trained to Use, Orchestrate It

Giving healthcare teams powerful AI tools without training undermines their ability to use potentially system-changing tools safely and effectively.

By Matt Scavetta

BioPharma, Artificial Intelligence

COO of Mayo Clinic Platform Believes De-identified Data Leads to Loss of Utility for Pharma, Other Third Parties

Mayo Clinic has about 100 petabytes of structured and unstructured EHR data, and about 28 petabytes have been de-identified, but in the Mayo Clinic way. Now that data capability is being combined with institutional expertise to provide a compelling case for pharma companies looking to leverage data, AI and provider expertise in drug development.

By Arundhati Parmar

BioPharma, Pharma

BridgeBio Stands Tall as Phase 3 Data Put Dwarfism Drug on Track for FDA Filing

Infigratinib achieved statistically significant improvement in growth rate and body composition in a Phase 3 clinical trial that tested the BridgeBio Pharma drug in achondroplasia, the most common form of dwarfism. Regulatory submissions are planned for later this year.

By Frank Vinluan

Health Tech, Startups, Providers

Female psychotherapist talking with a man via online video chat. Psychologist conducting an online therapy session with her patient.

Talkiatry Rakes In $210M to Scale Virtual Psychiatry Group

Telepsychiatry provider Talkiatry has raised a $210 million Series D round led by Perceptive Advisors, bringing its total funding to more than $400 million. CEO Robert Krayn said the company is focused on scaling its clinician-employed model and improving outcomes as competition intensifies across behavioral health and virtual care.

By Katie Adams

MedCity Influencers

Empathetic AI Nurses Can Vastly Improve Nurses’ Work and Patient Care

The AI revolution doesn't mean erasing the value of humans. It means giving nurses more time to do what they signed up to do — deliver care directly to patients.

By Tomas Gorny

MedCity Influencers

Blinded by Science: The Importance of RWD and Post-market Surveillance

When applied with a rigorous, subject-matter-expert guided process, AI-currated RWD is an essential resource giving life science organizations new power to monitor the diverse variety of ways drugs are actually utilized post-approval.

By Sujay Jadhav